Evidence map›Paper›PMID 30638129›Full record

ArticleStem cells and development2019

Exosomes Derived from Human Primed Mesenchymal Stem Cells Induce Mitosis and Potentiate Growth Factor Secretion.

Oliver Yuan, Clayton Lin, Joseph Wagner, Joehleen A Archard, Peter Deng, Julian Halmai, Gerhard Bauer, Kyle D Fink, Brian Fury, Nicholas H Perotti and 9 more

Open access · hybridAbstract read
In one paragraph

Article in Stem cells and development, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 40 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
40citing papers in PubMed, 1 pooled it
3.2field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

40 citing papers in PubMed, 1 synthesis or guideline pooled it, 54 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Review
  4. Article
  5. Review
  6. Review
  7. The role of exosomes in pathogenesis and the therapeutic efficacy of mesenchymal stem cell-derived exosomes against Parkinson's disease.Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology · 2023
    Review
  8. Review
  9. Review
  10. Review
  11. Review
  12. Article
  13. Review
  14. Review
  15. Article
  16. Review
  17. Article
  18. Article
  19. Sensory nerves in the spotlight of the stem cell niche.Stem cells translational medicine · 2021
    Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors at 2 institutions in 1 country.

Oliver Yuan1 Department of Otolaryngology, University of California, Davis, Davis, California.
Clayton Lin1 Department of Otolaryngology, University of California, Davis, Davis, California.
Joseph Wagner2 Drug Discovery Consortium, University of California, San Francisco, San Francisco, California.
Joehleen A Archard1 Department of Otolaryngology, University of California, Davis, Davis, California.
Peter Deng3 Department of Neurology, University of California, Davis, Davis, California.
Julian Halmai3 Department of Neurology, University of California, Davis, Davis, California.
Gerhard Bauer4 Good Manufacturing Practice Facility, University of California, Davis, Davis, California.
Kyle D Fink3 Department of Neurology, University of California, Davis, Davis, California.
Brian Fury4 Good Manufacturing Practice Facility, University of California, Davis, Davis, California.
Nicholas H Perotti4 Good Manufacturing Practice Facility, University of California, Davis, Davis, California.
Jon E Walker5 Stem Cell Program, University of California, Davis, Davis, California.
Kari Pollock5 Stem Cell Program, University of California, Davis, Davis, California.
Michelle Apperson3 Department of Neurology, University of California, Davis, Davis, California.
Janelle Butters3 Department of Neurology, University of California, Davis, Davis, California.
Peter Belafsky1 Department of Otolaryngology, University of California, Davis, Davis, California.
D Gregory Farwell1 Department of Otolaryngology, University of California, Davis, Davis, California.
Maggie Kuhn1 Department of Otolaryngology, University of California, Davis, Davis, California.
Jan Nolta5 Stem Cell Program, University of California, Davis, Davis, California.
Johnathon D Anderson1 Department of Otolaryngology, University of California, Davis, Davis, California.
University of California, Davis · USUniversity of California, San Francisco · US

Funding

Staff InvestigatorsP30CA093373 · NCI · UNIVERSITY OF CALIFORNIA DAVIS · PI Laura Marcu · 2002 to 2026
$84.9M
UC Davis Clinical and Translational Science CenterUL1TR001860 · NCATS · UNIVERSITY OF CALIFORNIA AT DAVIS · PI KENYON, NICHOLAS J., LYLES, COURTNEY REES · 2016 to 2025
$47.3M
Institutional Career Development Core (KL2)KL2TR001859 · NCATS · UNIVERSITY OF CALIFORNIA AT DAVIS · PI HOLMES, JAMES F. · 2016 to 2025
$10.1M
West Coast Central Comprehensive Metabolomics Resource Core (WC3MRC)U24DK097154 · NIDDK · UNIVERSITY OF CALIFORNIA AT DAVIS · PI FIEHN, OLIVER · 2012 to 2017
$9.9M
Training Program In Basic & Translational Cardiovascular ScienceT32HL086350 · NHLBI · UNIVERSITY OF CALIFORNIA AT DAVIS · PI Martin Cadeiras, David A. Liem · 2008 to 2026
$7.1M
MSCs engineered to produce Brain-Derived Neurotrophic Factor for the Treatment of Huntington's diseaseR01NS102486 · NINDS · UNIVERSITY OF CALIFORNIA AT DAVIS · PI Kyle Fink, Jan A. Nolta · 2017 to 2026
$3.7M
Direct cell to cell transfer of microRNA for tissue repairR01GM099688 · NIGMS · UNIVERSITY OF CALIFORNIA AT DAVIS · PI NOLTA, JAN A. · 2011 to 2015
$2.7M
Training Program in Biomolecular TechnologyT32GM008799 · NIGMS · UNIVERSITY OF CALIFORNIA DAVIS · PI LEACH, J. KENT · 2002 to 2016
$2.4M
Predoctoral Training in Pharmacological SciencesT32GM099608 · NIGMS · UNIVERSITY OF CALIFORNIA AT DAVIS · PI HELL, JOHANNES W · 2012 to 2021
$2.2M
Shared LSRII Cytometer Equipment Application - UC Davis Stem Cell ProgramS10RR026825 · NCRR · UNIVERSITY OF CALIFORNIA AT DAVIS · PI NOLTA, JAN A. · 2010 to 2010
$500k
NCATS NIH HHS KL2 TR001859NCATS NIH HHS UL1 TR001860NCI NIH HHS P30 CA093373NCRR NIH HHS S10 RR026825NHLBI NIH HHS T32 HL086350NIDDK NIH HHS U24 DK097154NIGMS NIH HHS R01 GM099688NIGMS NIH HHS T32 GM008799NIGMS NIH HHS T32 GM099608
6 · The paper itself

Abstract

Mesenchymal stem cells (MSCs) facilitate functional recovery in numerous animal models of inflammatory and ischemic tissue-related diseases with a growing body of research suggesting that exosomes mediate many of these therapeutic effects. It remains unclear, however, which types of proteins are packaged into exosomes compared with the cells from which they are derived. In this study, using comprehensive proteomic analysis, we demonstrated that human primed MSCs secrete exosomes (pMEX) that are packaged with markedly higher fractions of specific protein subclasses compared with their cells of origin, indicating regulation of their contents. Notably, we found that pMEX are also packaged with substantially elevated levels of extracellular-associated proteins. Fibronectin was the most abundant protein detected, and data established that fibronectin mediates the mitogenic properties of pMEX. In addition, treatment of SHSY5Y cells with pMEX induced the secretion of growth factors known to possess mitogenic and neurotrophic properties. Taken together, our comprehensive analysis indicates that pMEX are packaged with specific protein subtypes, which may provide a molecular basis for their distinct functional properties.

Indexed as

MitosisAdolescentAdultCell Line, TumorExosomesFemaleHumansIntercellular Signaling Peptides and ProteinsMaleMesenchymal Stem CellsMiddle AgedIntercellular Signaling Peptides and Proteinsexosomesextracellular matrixHiRIEF LC-MS/MSmesenchymal stem cellsproliferationproteomics

Identifiers

PMID30638129
PMCPMC6441283
OpenAlexW2910190385

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.